Currently out of the existing stock ratings of Frank Takkinen, 80 are a BUY (98.77%), 1 are a HOLD (1.23%).

Frank Takkinen

Work Performance Price Targets & Ratings Chart

Analyst Frank Takkinen works at LAKE STREET with a stock forecast success ratio of 33.29% fulfilled within 71.6 days on average.

Frank Takkinen’s has documented 158 price targets and ratings displayed on 20 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on CVRX, CVRx at 22-Jan-2024.

Wall Street Analyst Frank Takkinen

Analyst best performing recommendations are on CVRX (CVRX).
The best stock recommendation documented was for CVRX (CVRX) at 12/27/2023. The price target of $32 was fulfilled within 1 day with a profit of $1.25 (4.07%) receiving and performance score of 40.65.

Average potential price target upside

INSP Inspire Medical Systems NOTV Inotiv OSUR OraSure Technologies STXS Stereotaxis SNCE Science 37 Holdings APEN Apollo Endosurgery SLHG Skylight Health Group UPH Uphealth AORT Artivion PAVM PAVmed BTCY Biotricity EDAP EDAP TMS SA ICAD icad inc PROF Profound Medical Corp CVRX CVRx CLPT Clearpoint Neuro TELA Tela Bio APYX Apyx Medical BIOL BIOLASE NPCE Neuropace

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

250

$15.81 (6.75%)

250

29 days ago

3/7 (42.86%)

$36.5 (17.10%)

53

Buy

280

$45.81 (19.56%)

260

2 months 18 days ago

16/26 (61.54%)

$77.84 (38.50%)

208

Buy

240

$5.81 (2.48%)

210

3 months 9 days ago

11/12 (91.67%)

$53.9 (28.96%)

130

Buy

236

$1.81 (0.77%)

250

5 months 17 days ago

1/2 (50%)

$106.05 (81.61%)

153

Buy

210

$-24.19 (-10.33%)

350

5 months 17 days ago

6/7 (85.71%)

$80.05 (61.60%)

56

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Frank Takkinen is most bullish on?

Potential upside of $20.6 has been obtained for CVRX (CVRX)

Which stock is Frank Takkinen is most reserved on?

Potential downside of $0.62 has been obtained for STXS (STEREOTAXIS)

What Year was the first public recommendation made by Frank Takkinen?

On 2020

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?